None
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Continuous monitoring of hemodynamic parameters, age 18 years and above, gender not specified; 2. The subjects and/or their guardians must understand the purpose of the study, demonstrate sufficient adherence to the study protocol, and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. In the stage of unstable or rapid progression of disease, frequent medical intervention may be necessary; 2. Syndrome involving systemic infection or uncontrolled probe skin contamination or breach of probe skin contact site, or other important organ failure; 3. Pregnant or lactating women; 4. Women who have participated in other pharmaceutical or medical device clinical trials within the first month prior to screening; 5. Other circumstances where investigators believe that the subject should not participate in this clinical trial for the benefit of the subject.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The accuracy of blood hemodynamics monitoring; | — |
Secondary
| Measure | Time frame |
|---|---|
| Monitoring parameter consistency (Bland–Altman consistency analysis); | — |
Countries
China
Contacts
Shanghai Sixth People's Hospital